Skip to main content
Clinical Trials/NCT01418859
NCT01418859
Unknown
Not Applicable

Status and the Application of Topotecan at Post-operation Treatment of Cervical Cancer

Health Science Center of Xi'an Jiaotong University1 site in 1 country183 target enrollmentAugust 2011
ConditionsCervical Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
Health Science Center of Xi'an Jiaotong University
Enrollment
183
Locations
1
Last Updated
14 years ago

Overview

Brief Summary

The purpose of the research is to evaluate the effect of additional chemotherapy in postoperation therapy of cervical cancer patients with risk factors (big tumor, deep invasion or tumor thrombi in the vascular system).

Detailed Description

Cervical cancer has a very high morbidity. Many patients need additional therapy after surgery in order to elevate the survival rate and life quality. In this research, we are going to give additional therapy to patients who have big tumor, deep invasion or tumor thrombi in the vascular system after surgery. randomized control method will be used in this research, in order to compare the survival rate and side effects between radiation therapy only, concurrent chemoradiotherapy, and concurrent chemoradiotherapy with additional chemotherapy. 3D-CRT and Topotecan will be used in this research.

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
December 2015
Last Updated
14 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Health Science Center of Xi'an Jiaotong University
Responsible Party
Principal Investigator
Principal Investigator

Liu Zi

Profesor

Health Science Center of Xi'an Jiaotong University

Eligibility Criteria

Inclusion Criteria

  • patients who underwent the cervical cancer radical surgery in three months have higt risk factors which including deep stromal invasion,large primary tumour and/or lymphovascular spase invasion;
  • squamous carcinoma;
  • Gynecologic Oncology Group (GOG):0-2.

Exclusion Criteria

  • negative nodes,surgical margin,and/or parametrium;
  • No serious damage to the liver and kidney function, no hypertension,diabetes and other effects of therapy complications.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials